OMDA
Omada Health · Healthcare · Medical - Healthcare Information Services
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 12.51K | +6.0% | $260,500 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | TD Waterhouse Canada Inc. | 2.00K | 0.0% | $40,820 | 0.0% | Held | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 138 holders, 47.82M shares, $543.52M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 12.94K sh · $266,753
Officer, Director · 4.31K sh · $90,163
Officer, Director · 1.40K sh · $31,628
Officer · 400 sh · $9,013
Officer · 3.64K sh · $79,193
Officer, Director · 13.56K sh · $295,569
Officer · 600 sh · $13,510
Officer · 6.20K sh · $135,130
Officer · 644 sh · $13,995
Officer, Director · 5.60K sh · $135,901
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology